Gyre Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GYRE and other ETFs, options, and stocks.About GYRE
Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis).
GYRE Key Statistics
Stock Snapshot
With a market cap of 709.4M, Gyre Therapeutics(GYRE) trades at $7.82. The stock has a price-to-earnings ratio of 205.25.
During the trading day, Gyre Therapeutics(GYRE) stock saw an opening price of $7.83, a peak of —, and a bottom of —.
Trading volume for Gyre Therapeutics(GYRE) stock has reached 0, versus its average volume of 56.35K.
The stock's 52-week range extends from a low of $6.11 to a high of $13.75.
The stock's 52-week range extends from a low of $6.11 to a high of $13.75.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.